BioCentury
ARTICLE | Clinical News

Thalomid thalidomide: Phase II

December 11, 2000 8:00 AM UTC

In an 83-patient U.S. Phase II trial, 21 of 51 evaluable patients had a partial response to Thalomid treatment, and 8 transfusion-dependent patients were able to stop transfusions. The median duration...